Related Experiment Video
Updated: Mar 28, 2026
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
microRNA and Bone Cancer
1Department of Trauma and Orthopaedics, St. James Hospital, Dublin 8, Ireland. nugentmary@gmail.com.
Abstract:
MicroRNA molecules have a variety of roles in cellular development and proliferation processes, including normal osteogenesis. These effects are exerted through post-translational inhibition of target genes. Altered miRNA expression has been demonstrated in several cancers, both in the tumor tissue and in the peripheral circulation. This may influence carcinogenesis if the specific miRNA targets are encoded by tumor suppressor genes or oncogenes. To date, most research investigating the role of microRNAs and primary bone tumors has focused on osteosarcoma and Ewing sarcoma. Several microRNAs including the miR-34 family have been implicated in osteosarcoma tumorigenesis via effects on the Notch signaling pathway. Progression, invasion, and metastasis of osteosarcoma tumor cells is also influenced by microRNA expression. In addition, microRNA expression may affect the response to chemotherapy in osteosarcoma and thus hold potential for future use as either a prognostic indicator or a therapeutic target. The EWS-FLI1 fusion protein produced in Ewing sarcoma has been shown to induce changes in miRNA expression. MicroRNA expression profiling may have some potential for prediction of disease progression and survival in Ewing sarcoma. There is limited evidence to support a role for microRNAs in other primary bone tumors, either malignant or benign; however, early work is suggestive of involvement in chondrosarcoma, multiple osteochondromatosis, and giant cell tumors of bone.
Insights
MicroRNAs (miRNAs) play roles in bone development and cancer. Altered miRNA expression is linked to bone tumors like osteosarcoma and Ewing sarcoma, offering potential diagnostic and therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of cellular processes, including osteogenesis.
- Aberrant miRNA expression is observed in various cancers, impacting tumorigenesis through target gene modulation.
- Current research on miRNAs in primary bone tumors primarily focuses on osteosarcoma and Ewing sarcoma.
Purpose of the Study:
- To review the role of microRNAs in the development and progression of primary bone tumors.
- To explore the potential of miRNAs as diagnostic markers and therapeutic targets in bone cancers.
- To summarize current understanding and highlight areas for future research.
Main Methods:
- Literature review of studies investigating microRNA expression in primary bone tumors.
- Analysis of miRNA involvement in cellular pathways relevant to osteosarcoma and Ewing sarcoma.
- Examination of evidence for miRNA roles in other bone tumor types.
Main Results:
- Specific microRNAs, such as the miR-34 family, are implicated in osteosarcoma tumorigenesis via the Notch signaling pathway.
- miRNA expression influences osteosarcoma progression, invasion, metastasis, and chemotherapy response.
- In Ewing sarcoma, the EWS-FLI1 fusion protein alters miRNA expression, with profiling showing potential for predicting prognosis.
- Emerging evidence suggests miRNA involvement in chondrosarcoma, multiple osteochondromatosis, and giant cell tumors of bone.
Conclusions:
- MicroRNAs are significant players in primary bone tumor biology, particularly osteosarcoma and Ewing sarcoma.
- miRNA expression profiling holds promise for prognostic prediction and therapeutic strategies in bone cancers.
- Further research is needed to elucidate the role of miRNAs in a broader spectrum of primary bone tumors.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...